Why the study?
Mental health comorbidities are common in physical long-term health conditions, prompting evaluation of the COMPASS therapist-supported digital cognitive-behavioural therapy programme.
Does a therapist-supported digital cognitive-behavioural therapy programme (COMPASS) improve depression and anxiety in patients with long-term physical health conditions?
Does a therapist-supported digital cognitive-behavioural therapy programme (COMPASS) improve depression and anxiety in patients with long-term physical health conditions?
A therapist-supported digital CBT program (COMPASS) significantly improved self-reported depression, anxiety, and functional impairment in patients with long-term physical health conditions in a real-world NHS setting.
Should not yet change practice in long-term conditions; leaves open efficacy of COMPASS in randomized trials.
Background Mental health comorbidities are common in physical long-term health conditions. Aims We evaluate the effectiveness of COMPASS, a therapist-supported, digital cognitive–behavioural therapy programme specifically designed to treat anxiety/depression in the context of long-term conditions. We also investigate patient experiences of the programme. Method We utilised a mixed-methods, non-randomised design. We analysed pre–post data from 76 patients with long-term conditions who were receiving psychological treatment (COMPASS) via local NHS services, using paired sample t -tests and Cohen's d , with depression, anxiety, distress and functional impairment self-report scales. Qualitative interviews explored patients’ experiences of using COMPASS. Twenty-one semi-structured interviews were completed and underwent inductive thematic analysis. Results Patients who received COMPASS had significantly reduced depression (−2.47, 95% CI −3.7 to −1.3, P < 0.001; Cohen's d = −0.376), anxiety (−2.30, 95% CI −3.6 to −1.2, P < 0.001; Cohen's d = −0.420) and psychological distress (−4.87, 95% CI −7.0 to −2.7, P < 0.001; Cohen's d = −0.422) and significantly improved functional impairment (−3.00, 95% CI −4.8 to −1.2, P ≤ 0.001; Cohen's d = −0.282). Effect sizes were larger when analyses included only patients with clinically significant baseline symptoms: depression (−4.02, 95% CI −5.6 to −2.5, P < 0.001; Cohen's d = −0.701), anxiety (−3.60, 95% CI −5.3 to −1.9, P < 0.001; Cohen's d = −0.739), psychological distress (−5.58, 95% CI −7.9 to −3.2, P < 0.001; Cohen's d = −0.523), functional impairment (−3.28, 95% CI −5.4 to −1.1, P ≤ 0.001; Cohen's d = −0.355). Qualitative analysis yielded two meta-themes: engagement and integration of mental and physical health. Conclusions Results suggest that COMPASS is effective in NHS settings, and is acceptable to patients. Content tailored to long-term conditions, therapist support and clear delivery strategies should be prioritised to aid intervention implementation.
No takes yet. Share an insight, caveat, or question.
Seaton et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: